キプレスチュアブル錠５ｍｇ
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00471 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 50 |
| 日本商品名（例） | キプレスチュアブル錠５ｍｇ, キプレスチュアブル錠５ｍｇ（選）, キプレスＯＤ錠１０ｍｇ |
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | intrinsic asthma | 99% | DL |
| 2 | allergic asthma | 99% | DL |
| 3 | bronchitis | 99% | DL |
| 4 | atopic eczema | 99% | DL |
| 5 | asthma | 99% | DL |
| 6 | obstructive lung disease | 99% | DL |
| 7 | asthma-related traits, susceptibility to | 99% | DL |
| 8 | 2-hydroxyethyl methacrylate sensitization | 98% | DL |
| 9 | uterine polyp | 98% | DL |
| 10 | polyp of vocal cord | 98% | DL |
| 11 | polyp of middle ear | 98% | DL |
| 12 | fibroepithelial polyp | 98% | DL |
| 13 | bronchial neoplasm (disease) | 98% | DL |
| 14 | polyp of vulva | 98% | DL |
| 15 | polyp of frontal sinus | 98% | DL |
| 16 | polyp of ureter | 98% | DL |
| 17 | polyp of external auditory canal | 98% | DL |
| 18 | neoplastic polyp | 98% | DL |
| 19 | epulis | 98% | DL |
| 20 | dermatitis, atopic | 97% | DL |
| 21 | rheumatoid arthritis | 97% | DL |
| 22 | laryngotracheitis | 97% | DL |
| 23 | indolent plasma cell myeloma | 96% | DL |
| 24 | nasal cavity polyp | 95% | DL |
| 25 | papillary conjunctivitis | 95% | DL |
| 26 | brachydactyly-syndactyly syndrome | 95% | DL |
| 27 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | 94% | DL |
| 28 | seborrheic dermatitis | 94% | DL |
| 29 | plasma cell myeloma | 94% | DL |
| 30 | dermatitis | 93% | DL |
| 31 | vulvar inverted follicular keratosis | 92% | DL |
| 32 | Laubry-Pezzi syndrome | 92% | DL |
| 33 | respiratory malformation | 92% | DL |
| 34 | seborrheic keratosis | 92% | DL |
| 35 | contact dermatitis | 92% | DL |
| 36 | genetic syndromic Pierre Robin syndrome | 91% | DL |
| 37 | interventricular septum aneurysm | 91% | DL |
| 38 | heart disease | 91% | DL |
| 39 | acrodermatitis chronica atrophicans | 91% | DL |
| 40 | phototoxic dermatitis | 91% | DL |
| 41 | Pierre Robin syndrome associated with a chromosomal anomaly | 91% | DL |
| 42 | pulmonary valve disease | 90% | DL |
| 43 | orofacial clefting syndrome | 90% | DL |
| 44 | acne keloid | 90% | DL |
| 45 | partial deletion of the long arm of chromosome 7 | 90% | DL |
| 46 | mitral valve disease | 90% | DL |
| 47 | disorder of fucoglycosan synthesis | 90% | DL |
| 48 | Jeune syndrome situs inversus | 90% | DL |
| 49 | vasomotor rhinitis | 5% | DL |
| 50 | allergic rhinitis | 0% | DL |
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。